Granexin

Published

dm+d

Unassigned

New Medicines

Diabetic foot ulcer

Information

New molecular entity
FirstString Research
FirstString Research

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Granexin stabilises gap junctions & tight junctions of endothelial cells during the wound healing process which leads to increased coordination of cellular communication, dampened excessive inflammatory response, & increase in normal tissue regeneration.
The 2014-2016 National Diabetes Foot Care Audit for England and Wales notes more than 60,000 people with diabetes in England are thought to have foot ulcers at any given time [1].
Diabetic foot ulcer
Topical

Evidence based evaluations